Bone marrow mononuclear cells (BMMNCs) obtained from newly diagnosed AML patients showed markedly elevated expression of the NLRP3 pathway; however, the results for specific components varied between the studies. The gene discussed is NLRP3; the disease is acute myeloid leukemia.